Entity usage

Showing below up to 50 results in range #1 to #50.

1. Book review of “Disease mapping: From foundations to multidimensional modeling”: Label: en
2. A penalized structural equation modeling method accounting for secondary phenotypes for variable selection on genetically regulated expression from PrediXcan for Alzheimer's disease: Label: en
3. Improving inference for nonlinear state‐space models of animal population dynamics given biased sequential life stage data: Label: en
4. Repeated measures random forests (RMRF): Identifying factors associated with nocturnal hypoglycemia: Label: en
5. Exploiting nonsystematic covariate monitoring to broaden the scope of evidence about the causal effects of adaptive treatment strategies: Label: en
6. A Bayes factor approach with informative prior for rare genetic variant analysis from next generation sequencing data: Label: en
7. Bayesian analysis of survival data with missing censoring indicators: Label: en
8. Ensemble clustering for step data via binning: Label: en
9. Testing tumors from different anatomic sites for clonal relatedness using somatic mutation data: Label: en
10. Marginal analysis of multiple outcomes with informative cluster size: Label: en
11. Generalized reliability based on distances: Label: en
12. Efficient screening of predictive biomarkers for individual treatment selection: Label: en
13. Upper bound estimators of the population size based on ordinal models for capture‐recapture experiments: Label: en
14. Zero‐inflated Poisson factor model with application to microbiome read counts: Label: en
15. Bayesian latent multi‐state modeling for nonequidistant longitudinal electronic health records: Label: en
16. Case contamination in electronic health records based case‐control studies: Label: en
17. Analyzing wearable device data using marked point processes: Label: en
18. Rejoinder to Discussions on “Approval policies for modifications to machine learning‐based software as a medical device: A study of bio‐creep”: Label: en
19. Discussion on “Approval policies for modifications to machine learning‐based software as a medical device: A study of biocreep” by Jean Feng, Scott Emerson, and Noah Simon: Label: en
20. Discussion on “Approval policies for modifications to machine learning‐based software as a medical device: A study of bio‐creep” by Jean Feng, Scott Emerson, and Noah Simon: Label: en
21. Approval policies for modifications to machine learning‐based software as a medical device: A study of bio‐creep: Label: en
22. Rejoinder to “Nonparametric variable importance assessment using machine learning techniques”: Label: en
23. Correction to "A penalized framework for distributed lag non‐linear models" by Antonio Gasparrini, Fabian Scheipl, Ben Armstrong, and Michael G. Kenward; 73, 938–948, September 2017: Label: en
24. Bayesian data fusion: Probabilistic sensitivity analysis for unmeasured confounding using informative priors based on secondary data: Label: en
25. Small‐sample inference for cluster‐based outcome‐dependent sampling schemes in resource‐limited settings: Investigating low birthweight in Rwanda: Label: en
26. Determination and estimation of optimal quarantine duration for infectious diseases with application to data analysis of COVID‐19: Label: en
27. Synthesizing external aggregated information in the presence of population heterogeneity: A penalized empirical likelihood approach: Label: en
28. Regression‐based negative control of homophily in dyadic peer effect analysis: Label: en
29. Variance reduction in the inverse probability weighted estimators for the average treatment effect using the propensity score: Label: en
30. Global sensitivity analysis of randomized trials with nonmonotone missing binary outcomes: Application to studies of substance use disorders: Label: en
31. Recruitment prediction for multicenter clinical trials based on a hierarchical Poisson–gamma model: Asymptotic analysis and improved intervals: Label: en
32. Causal interaction trees: Finding subgroups with heterogeneous treatment effects in observational data: Label: en
33. Sparse linear discriminant analysis for multiview structured data: Label: en
34. A model for analyzing clustered occurrence data: Label: en
35. A kernel regression model for panel count data with nonparametric covariate functions: Label: en
36. Simultaneous estimation of cluster number and feature sparsity in high‐dimensional cluster analysis: Label: en
37. Spatial factor modeling: A Bayesian matrix‐normal approach for misaligned data: Label: en
38. Geostatistical modeling of positive‐definite matrices: An application to diffusion tensor imaging: Label: en
39. Bayesian spatial homogeneity pursuit for survival data with an application to the SEER respiratory cancer data: Label: en
40. Gaussian graphical model‐based heterogeneity analysis via penalized fusion: Label: en
41. Information‐incorporated Gaussian graphical model for gene expression data: Label: en
42. On polygenic risk scores for complex traits prediction: Label: en
43. A generalized robust allele‐based genetic association test: Label: en
44. Varying coefficient frailty models with applications in single molecular experiments: Label: en
45. Cox regression model under dependent truncation: Label: en
46. Semiparametric estimation of the nonmixture cure model with auxiliary survival information: Label: en
47. Rejoinder: Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes: Label: en
48. Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease: Label: en
49. Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes” by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, an: Label: en
50. Nonparametric estimation of Spearman's rank correlation with bivariate survival data: Label: en